Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Verghese PB, Castellano JM, Holtzman DM.

Lancet Neurol. 2011 Mar;10(3):241-52. doi: 10.1016/S1474-4422(10)70325-2. Review.

2.

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC.

Ann Neurol. 2011 Jan;69(1):181-92. doi: 10.1002/ana.22248.

3.

Neuropathology and amyloid-β spectrum in a bapineuzumab immunotherapy recipient.

Roher AE, Maarouf CL, Daugs ID, Kokjohn TA, Hunter JM, Sabbagh MN, Beach TG.

J Alzheimers Dis. 2011;24(2):315-25. doi: 10.3233/JAD-2011-101809.

4.

Genetics of Alzheimer disease.

Bekris LM, Yu CE, Bird TD, Tsuang DW.

J Geriatr Psychiatry Neurol. 2010 Dec;23(4):213-27. doi: 10.1177/0891988710383571. Review.

5.

The biochemical aftermath of anti-amyloid immunotherapy.

Maarouf CL, Daugs ID, Kokjohn TA, Kalback WM, Patton RL, Luehrs DC, Masliah E, Nicoll JA, Sabbagh MN, Beach TG, Castaño EM, Roher AE.

Mol Neurodegener. 2010 Oct 7;5:39. doi: 10.1186/1750-1326-5-39.

6.

Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis.

Oh KJ, Perez SE, Lagalwar S, Vana L, Binder L, Mufson EJ.

Int J Alzheimers Dis. 2010 Jul 15;2010. pii: 780102. doi: 10.4061/2010/780102.

7.

Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.

Boche D, Denham N, Holmes C, Nicoll JA.

Acta Neuropathol. 2010 Sep;120(3):369-84. doi: 10.1007/s00401-010-0719-5. Epub 2010 Jul 15. Review.

PMID:
20632020
8.

Abeta-directed single-chain antibody delivery via a serotype-1 AAV vector improves learning behavior and pathology in Alzheimer's disease mice.

Ryan DA, Mastrangelo MA, Narrow WC, Sullivan MA, Federoff HJ, Bowers WJ.

Mol Ther. 2010 Aug;18(8):1471-81. doi: 10.1038/mt.2010.111. Epub 2010 Jun 15.

9.

Astrocytic A beta 1-42 uptake is determined by A beta-aggregation state and the presence of amyloid-associated proteins.

Nielsen HM, Mulder SD, Beliën JA, Musters RJ, Eikelenboom P, Veerhuis R.

Glia. 2010 Aug;58(10):1235-46. doi: 10.1002/glia.21004.

PMID:
20544859
10.

Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain.

Ghosal K, Vogt DL, Liang M, Shen Y, Lamb BT, Pimplikar SW.

Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18367-72. doi: 10.1073/pnas.0907652106. Epub 2009 Oct 16.

11.

Interferon-{gamma} differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice.

Mastrangelo MA, Sudol KL, Narrow WC, Bowers WJ.

Am J Pathol. 2009 Nov;175(5):2076-88. doi: 10.2353/ajpath.2009.090059. Epub 2009 Oct 1.

12.

Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions.

Kokjohn TA, Roher AE.

Alzheimers Dement. 2009 Jul;5(4):340-7. doi: 10.1016/j.jalz.2009.03.002. Review.

13.

Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease.

Overk CR, Kelley CM, Mufson EJ.

Neurobiol Dis. 2009 Sep;35(3):415-25. doi: 10.1016/j.nbd.2009.06.004. Epub 2009 Jun 12.

14.
15.

APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.

Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M.

Nature. 2009 Feb 19;457(7232):981-9. doi: 10.1038/nature07767.

16.

Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations.

Maarouf CL, Daugs ID, Spina S, Vidal R, Kokjohn TA, Patton RL, Kalback WM, Luehrs DC, Walker DG, Castaño EM, Beach TG, Ghetti B, Roher AE.

Mol Neurodegener. 2008 Nov 20;3:20. doi: 10.1186/1750-1326-3-20.

17.

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA.

Brain. 2008 Dec;131(Pt 12):3299-310. doi: 10.1093/brain/awn261. Epub 2008 Oct 25.

PMID:
18953056
18.

Evolution of the aging brain transcriptome and synaptic regulation.

Loerch PM, Lu T, Dakin KA, Vann JM, Isaacs A, Geula C, Wang J, Pan Y, Gabuzda DH, Li C, Prolla TA, Yankner BA.

PLoS One. 2008 Oct 2;3(10):e3329. doi: 10.1371/journal.pone.0003329.

20.

Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer's disease.

Rodríguez JJ, Jones VC, Tabuchi M, Allan SM, Knight EM, LaFerla FM, Oddo S, Verkhratsky A.

PLoS One. 2008 Aug 13;3(8):e2935. doi: 10.1371/journal.pone.0002935.

Supplemental Content

Support Center